# Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

> **NCT02342392** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universiti Sains Malaysia** · enrollment: 36 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT02342392
- **Lead sponsor:** Universiti Sains Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02342392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02342392, "Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02342392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*